The federal government’s current goals for HIV care and treatment may help cut new infections by up to 67 percent across the U.S. in 2030, according to a new study. 

Researchers at Georgia State University and the University at Albany-SUNY said that the government intends to use new models and tools to deliver HIV care and prevention interventions to citizens in the coming years as part of a recently announced anti-HIV campaign, EurekAlert reported Friday.

The administration said it aims to cut the infections by 90 percent in the next 10 years. However, researchers said it is unlikely to achieve the goal. But the use of emerging tools and methods, as well as increased investment in HIV care and treatment, could help reduce 67 percent of infections in the next decade.

The team predicts that the government could meet internationally accepted targets for diagnosis and care by 2025 and prevent an additional 20 percent of transmissions within the decade. To achieve such goals, the researchers suggested that the government increase the percentage of HIV patients receiving care from under 70 percent to 95 percent in 6 years and to target 40 percent pre-exposure prophylaxis coverage among people at risk of HIV.

“It is important to set HIV prevention goals that are ambitious, but realistic,” said Heather Bradley, lead author of the study and assistant professor in the School of Public Health at Georgia State. “Treating enough people to meaningfully reduce new HIV infections will require us to confront issues like poverty, unstable housing and mental health conditions that keep people living with HIV from accessing care,” he continued.

The findings, published in the journal AIDS and Behavior, come from the analysis of latest HIV surveillance data from the Centers for Disease Control and Prevention and the government’s projected new infections in the coming years. 

“Our study estimates how much improvement is possible and can help quantify what it would take to get there,” Bradley said.

To date, the government is facing challenges to reduce HIV infections across the U.S. The efforts to treat key minority and risk groups have been relatively stagnant, researchers said.